{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T17:01:32Z","timestamp":1792602092641,"version":"4.5.0"},"reference-count":44,"publisher":"Impact Journals, LLC","issue":"21","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2016,5,24]]},"DOI":"10.18632\/oncotarget.8845","type":"journal-article","created":{"date-parts":[[2016,4,20]],"date-time":"2016-04-20T16:17:00Z","timestamp":1461169020000},"page":"31067-31078","source":"Crossref","is-referenced-by-count":24,"title":["CYR61 (CCN1) is a metastatic biomarker of gastric cardia adenocarcinoma"],"prefix":"10.18632","volume":"7","author":[{"given":"Jing","family":"Wei","sequence":"first","affiliation":[{"name":"School of Medicine, Jiangsu University, Zhenjiang, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanzhen","family":"Yu","sequence":"additional","affiliation":[{"name":"Changzheng Hospital, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genbao","family":"Shao","sequence":"additional","affiliation":[{"name":"School of Medicine, Jiangsu University, Zhenjiang, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aiqin","family":"Sun","sequence":"additional","affiliation":[{"name":"School of Medicine, Jiangsu University, Zhenjiang, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miao","family":"Chen","sequence":"additional","affiliation":[{"name":"School of Medicine, Jiangsu University, Zhenjiang, Jiangsu, China"},{"name":"The Affiliated Hospital, Jiangsu University, Zhenjiang, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wannian","family":"Yang","sequence":"additional","affiliation":[{"name":"School of Medicine, Jiangsu University, Zhenjiang, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiong","family":"Lin","sequence":"additional","affiliation":[{"name":"School of Medicine, Jiangsu University, Zhenjiang, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2016,4,20]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.semradonc.2012.09.008","article-title":"Epidemiology and risk factors for gastroesophageal junction tumors: understanding the rising incidence of this disease","volume":"23","author":"Vaughan","year":"2013","journal-title":"Semin Radiat Oncol"},{"key":"2","first-page":"577","article-title":"Clinicopathologic characteristics outcome of adenocarcinoma of the human gastric cardia in comparison with carcinoma of other regions of the stomach","volume":"180","author":"Sugimachi","year":"1995","journal-title":"J Am Coll Surg"},{"key":"3","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/00000658-200009000-00007","article-title":"Adenocarcinoma of the esophagogastric junction: results of surgical therapy based on anatomical\/topographic classification in 1,002 consecutive patients","volume":"232","author":"Stein","year":"2000","journal-title":"Ann Surg"},{"key":"4","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1097\/00000658-198007000-00010","article-title":"Adenocarcinoma of the gastric cardia. The choice of gastrectomy","volume":"192","author":"Fortner","year":"1980","journal-title":"Ann Surg"},{"key":"5","first-page":"423","article-title":"Prognostic differences of adenocarcinoma arising from the cardia the upper third of the stomach","volume":"59","author":"Hioki","year":"1993","journal-title":"Am Surg"},{"key":"6","unstructured":"Guo, Dong, Guo, Shen, Guo, Kuang, Yang. Decreased expression and frequent promoter hypermethylation of RASSF2 and RASSF6 correlate with malignant progression and poor prognosis of gastric cardia adenocarcinoma. Mol Carcinog. In press."},{"key":"7","doi-asserted-by":"crossref","first-page":"646","DOI":"10.4149\/neo_2015_078","article-title":"FBXO32, a new TGF-\u03b2\/Smad signaling pathway target gene, is epigenetically inactivated in gastric cardia adenocarcinoma","volume":"62","author":"Dong","year":"2015","journal-title":"Neoplasma"},{"key":"8","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1002\/ijc.28223","article-title":"Methylation-mediated repression of GADD45A and GADD45G expression in gastric cardia adenocarcinoma","volume":"133","author":"Yang","year":"2013","journal-title":"Int J Cancer"},{"key":"9","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s10238-012-0204-7","article-title":"Aberrant methylation and loss expression of RKIP is associated with tumor progression and poor prognosis in gastric cardia adenocarcinoma","volume":"30","author":"Yang","year":"2013","journal-title":"Clin Exp Metastasis"},{"key":"10","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1271\/bbb.120132","article-title":"Expression of the c-Met proto-oncogene and Integrin \u03b15\u03b21 in human gastric cardia adenocarcinoma","volume":"76","author":"Wang","year":"2012","journal-title":"Biosci Biotechnol Biochem"},{"key":"11","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1007\/s00268-013-2256-6","article-title":"HER2 expression in carcinomas of the true cardia (Siewert type II esophagogastric junction carcinoma)","volume":"38","author":"Kushima","year":"2014","journal-title":"World J Surg"},{"key":"12","doi-asserted-by":"crossref","first-page":"5029","DOI":"10.1007\/s13277-014-1664-z","article-title":"Differential expression of Pim-3, c-Myc, and p-p27 proteins in adenocarcinomas of the gastric cardia and distal stomach","volume":"35","author":"Li","year":"2014","journal-title":"Tumour Biol"},{"key":"13","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1177\/1066896911412181","article-title":"Expression of SIRT1 in gastric cardiac cancer and its clinicopathologic significance","volume":"19","author":"Yang","year":"2011","journal-title":"Int J Surg Pathol"},{"key":"14","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1158\/1055-9965.EPI-13-1329","article-title":"PLCE1 mRNA and protein expression and survival of patients with esophageal squamous cell carcinoma and gastric adenocarcinoma","volume":"23","author":"Taylor","year":"2014","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"15","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.clinre.2014.11.010","article-title":"Down-regulation of C\/EBP homologous protein (CHOP) expression in gastric cardia adenocarcinoma: Their relationship with clinicopathological parameters and prognostic significance","volume":"39","author":"Feng","year":"2015","journal-title":"Clin Res Hepatol Gastroenterol"},{"issue":"Suppl 1","key":"16","first-page":"E87","article-title":"A functional polymorphism in MIR196A2 is associated with risk and prognosis of gastric cancer","volume":"52","author":"Zhang","year":"2013","journal-title":"Mol Carcinog"},{"key":"17","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s00438-013-0810-4","article-title":"Microarray expression profile analysis of long non-coding RNAs of advanced stage human gastric cardia adenocarcinoma","volume":"289","author":"Gao","year":"2014","journal-title":"Mol Genet Genomics"},{"key":"18","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1007\/s13277-014-2912-y","article-title":"Associations between polymorphisms of HOTAIR and risk of gastric cardia adenocarcinoma in a population of north China","volume":"36","author":"Xu","year":"2015","journal-title":"Tumour Biol"},{"key":"19","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1186\/1476-4598-13-248","article-title":"Nedd4-1 is an exceptional prognostic biomarker for gastric cardia adenocarcinoma and functionally associated with metastasis","volume":"13","author":"Lin","year":"2014","journal-title":"Mol Cancer"},{"key":"20","first-page":"189","article-title":"The connective tissue growth factor\/cysteine-rich 61\/nephroblastoma overexpressed (CCN) family","volume":"20","author":"Brigstock","year":"1999","journal-title":"Endocr Rev"},{"key":"21","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.1038\/onc.2014.251","article-title":"Geranylgeranylation signals to the Hippo pathway for breast cancer cell proliferation and migration","volume":"34","author":"Yang","year":"2015","journal-title":"Oncogene"},{"key":"22","doi-asserted-by":"crossref","first-page":"390","DOI":"10.4161\/cbt.23788","article-title":"Emerging roles of TEAD transcription factors and its coactivators in cancers","volume":"14","author":"Hong","year":"2013","journal-title":"Cancer Biol Ther"},{"key":"23","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1016\/j.cellsig.2014.07.031","article-title":"CD44 acts through RhoA to regulate YAP signaling","volume":"26","author":"Bi","year":"2014","journal-title":"Cell Signal"},{"key":"24","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.cell.2015.10.044","article-title":"Hippo Pathway in Organ Size Control, Tissue Homeostasis, and Cancer","volume":"163","author":"Guan","year":"2015","journal-title":"Cell"},{"key":"25","doi-asserted-by":"crossref","first-page":"E2441","DOI":"10.1073\/pnas.1212021109","article-title":"The Hippo pathway target, YAP, promotes metastasis through its TEAD-interaction domain","volume":"109","author":"Hynes","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"26","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/jid.2013.319","article-title":"Pro-invasive activity of the Hippo pathway effectors YAP and TAZ in cutaneous melanoma","volume":"134","author":"Mauviel","year":"2014","journal-title":"J Invest Dermatol"},{"key":"27","doi-asserted-by":"crossref","first-page":"998","DOI":"10.2741\/1594","article-title":"CCN proteins and cancer: two to tango","volume":"10","author":"Perbal","year":"2005","journal-title":"Front Biosci"},{"key":"28","doi-asserted-by":"crossref","first-page":"6355","DOI":"10.1073\/pnas.95.11.6355","article-title":"CYR61, a product of a growth factor-inducible immediate early gene, promotes angiogenesis and tumor growth","volume":"95","author":"Lau","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"29","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/j.humpath.2014.02.007","article-title":"3rd Matricellular protein CCN1 (CYR61) expression is associated with high-grade ductal carcinoma in situ","volume":"45","author":"Haines","year":"2014","journal-title":"Hum Pathol"},{"key":"30","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.ejso.2011.05.009","article-title":"Expression of cysteine-rich 61 is correlated with poor prognosis in patients with esophageal squamous cell carcinoma","volume":"37","author":"Li","year":"2011","journal-title":"Eur J Surg Oncol"},{"key":"31","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s12032-014-0117-2","article-title":"CYR61 overexpression associated with the development and poor prognosis of ovarian carcinoma","volume":"31","author":"Jiang","year":"2014","journal-title":"Med Oncol"},{"key":"32","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1002\/ijc.23967","article-title":"Reduction of TIP30 correlates with poor prognosis of gastric cancer patients and its restoration drastically inhibits tumor growth and metastasis","volume":"124","author":"Fan","year":"2009","journal-title":"Int J Cancer"},{"key":"33","doi-asserted-by":"crossref","first-page":"5809","DOI":"10.1158\/1078-0432.CCR-04-2639","article-title":"Cyr61 induces gastric cancer cell motility\/invasion via activation of the integrin\/nuclear factor-kappaB\/cyclooxygenase-2 signaling pathway","volume":"11","author":"Kuo","year":"2005","journal-title":"Clin Cancer Res"},{"key":"34","doi-asserted-by":"crossref","first-page":"E89","DOI":"10.1073\/pnas.1319190110","article-title":"Interplay of mevalonate and Hippo pathways regulates RHAMM transcription via YAP to modulate breast cancer cell motility","volume":"111","author":"Huang","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"35","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/ncb2936","article-title":"Metabolic control of YAP and TAZ by the mevalonate pathway","volume":"16","author":"Del Sal","year":"2014","journal-title":"Nat Cell Biol"},{"key":"36","doi-asserted-by":"crossref","first-page":"3149","DOI":"10.1007\/s00018-011-0778-3","article-title":"CCN1\/CYR61: the very model of a modern matricellular protein","volume":"68","author":"Lau","year":"2011","journal-title":"Cell Mol Life Sci"},{"key":"37","doi-asserted-by":"crossref","first-page":"5196","DOI":"10.1158\/1078-0432.CCR-11-1758","article-title":"Molecular pathways: emerging pathways mediating growth, invasion, and metastasis of tumors progressing in an irradiated microenvironment","volume":"18","author":"R\u00fcegg","year":"2012","journal-title":"Clin Cancer Res"},{"key":"38","doi-asserted-by":"crossref","first-page":"e35754","DOI":"10.1371\/journal.pone.0035754","article-title":"Cyr61\/CCN1 is regulated by Wnt\/\u03b2-catenin signaling and plays an important role in the progression of hepatocellular carcinoma","volume":"7","author":"Si","year":"2012","journal-title":"PLoS One"},{"key":"39","doi-asserted-by":"crossref","first-page":"38569","DOI":"10.1074\/jbc.M112.389064","article-title":"The matricellular protein CCN1\/Cyr61 is a critical regulator of Sonic Hedgehog in pancreatic carcinogenesis","volume":"287","author":"Banerjee","year":"2012","journal-title":"J Biol Chem"},{"key":"40","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1158\/0008-5472.CAN-03-0245","article-title":"Expression of the receptor tyrosine kinase Axl promotes ocular melanoma cell survival","volume":"64","author":"Polans","year":"2004","journal-title":"Cancer Res"},{"key":"41","doi-asserted-by":"crossref","first-page":"53087","DOI":"10.1074\/jbc.M410254200","article-title":"Cyr61 suppresses growth of human endometrial cancer cells","volume":"279","author":"Koeffler","year":"2004","journal-title":"J Biol Chem"},{"key":"42","doi-asserted-by":"crossref","first-page":"4847","DOI":"10.1038\/sj.onc.1207628","article-title":"Cyr61 suppresses the growth of non-small-cell lung cancer cells via the beta-catenin-c-myc-p53 pathway","volume":"23","author":"Koeffler","year":"2004","journal-title":"Oncogene"},{"key":"43","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1080\/02770900701512597","article-title":"CYR61: a new measure of lung cancer outcome","volume":"25","author":"Koeffler","year":"2007","journal-title":"Cancer Invest"},{"key":"44","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1159\/000121000","article-title":"CYR61 downregulation correlates with tumor progression by promoting MMP-7 expression in human gastric carcinoma","volume":"73","author":"Ito","year":"2007","journal-title":"Oncology"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.8845","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,11]],"date-time":"2020-05-11T16:25:22Z","timestamp":1589214322000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.8845"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,20]]},"references-count":44,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2016,5,24]]}},"alternative-id":["8845","27105510"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.8845","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,20]]}}}